CA1215304A - Test for the determination of paternity and the establishment of individual identity - Google Patents

Test for the determination of paternity and the establishment of individual identity

Info

Publication number
CA1215304A
CA1215304A CA000448439A CA448439A CA1215304A CA 1215304 A CA1215304 A CA 1215304A CA 000448439 A CA000448439 A CA 000448439A CA 448439 A CA448439 A CA 448439A CA 1215304 A CA1215304 A CA 1215304A
Authority
CA
Canada
Prior art keywords
dna
individual
probe
organism
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000448439A
Other languages
French (fr)
Inventor
Jeffrey Glassberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifecodes Corp
Original Assignee
Actagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actagen Inc filed Critical Actagen Inc
Application granted granted Critical
Publication of CA1215304A publication Critical patent/CA1215304A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Abstract

ABSTRACT
This invention relates to a method for identification of individual members of a species of organism. The identification is based upon an analysis of DNA length polymorphisms generated by the action of restriction endonucleases.

Description

S;304 1 A TEST FOR TlIE DETE~`IINATIO~l OF PATERNITY ?~D FOR
TI~E ESTABLISHr~ENT OF I~DIVI~UAL GENETIC IDENTITY

This invention relates to a new and improved 10 diagnostic test applied to the determination of paternity and for the establishment of individual genetic identityO It should be noted that~although, as is the practice in the art, a test is referred to as a paternity test; there is nothing which precludes its employment in cases of disputed 15 maternity.

There are numerous situations when the ability to determine an individual's identity is of importance; for example, the matching of physical evidence left at the scene 20 of a crime with a particular suspect, the establishing of the identity of an individual in relation to his/her mother or father as in the determination of paternity or more generally when establishing the genetic identity of a strain of a virus, bacterium, alga, fungus, plant or animal. Some of the tests employed for such determinations rely upon the identification of polymorphic proteins in the plasma, from the surface, or extracted from within the cells of the individuals in question.
The well known human ABO blood group substances may 3o be used by way of explanation. The ABO blood group substances are carbohydrate in composition and are svnthesized by enzymes which are the products of a single human gene. One form of the gene (the A allele) produces an enzyme used in the synthesis of A-type blood, while another form of the gene (the B allele) produces an enzyme used in the synthesis of B-type blood. The absence of both alleles ~2~530~

1 lresults in the production of O-type blood, while the presence of both alleles results in the production of AB-type blood. The ABO substances possess antigenic properties and may be detected immunologically by reaction with the 5 appropriate antisera. It is the differential reac~ivity of these substances with said antisera which forms the basis of the A, B, O and AB blood type groupings.
If everyone possessed the same blood type, the substance would be useless in discriminating among lO individuals. The fact that the blood group substances exist in several forms (i.e., are polymorphic) allows for discrimination. However, in terms of its power to exclude, as in cases of disputed paternity, not only is the number of different alleles important, but also the frequencies with 15 which those alleles occur. Since these allele frequencies vary among populations, the efficacy of exclusion also varies. The power of a test to exclude is represented by its exclusion capability, a numerical value ranging from 0 to 1Ø The exclusion capability of the ABO system among 20 American blacks is .1774 while among American Caucasians it is .1342. The exclusion capability increases to .1830 for Swedes and to .1917 for Japanese.
One approach to increase the exclusion capability has been to expand the analysis to include other polymorphic substances. In Sweden, twelve polymorphic substances are analyzed. The overall exclusion capability of this battery of tests approaches .870. The addition of more systems to the set, even if highly informative, will not increase the cumulative probability greatly, once the number of systems 3o already involved is large. A survey of 25 systems based on immunological tests (Antigen-Antibody reactions) revealed a cumulative probability of non-paternity of .7694 while a 12~53Q~

l similar analysis of 32 systems based on biochemical tests (enzyme reactions or electrophoretic mobility) yielded a value of .9512. The combined 57 systems still only yielded an exclusion value of .9887. Extensive investiyations are 5 not practical in terms of a paternity testing program since many of the systems, because of cost, paucity of reagents, technical complexity, low reliability, and/or insufficient experience are not considered suitable for routine work.
It is well known in the forensic sciences to employ lO multiple test systems for the determination of identity. For example, in addition to the AB0 blood group antigens, MN and Rh antigens are also analyzed. If the test sample is liquid Le and Se antigens may also be included. Three red blood cell enzymes acid phosphatase, phosphoglucomutase, and 15 esterase D are examined for the presence of electrophoretic variants. Finally, tests for serum proteins such as haptoglobins are also employed. As was the case for the determination of paternity, the extent of these forensic investigations is also limited by cost, technical complexity and low reliability.
The above practical considerations not withstanding, a more serious theoretical problem plagues all of the existing tests. Since the tests are based on the analysis of a protein or its activity, it is the gene product and not the gene itself which is the subject of the investigation. In accord with the instant inventions disclosed hereinafter, it is preferable to analyze the gene directly rather than the product of its expression, in situations where paternity is of interest, because of the 3o degeneracy that is inherent in the process by which genetic information is expressed.

~S3~

l The flow of genetic information in cells is well known. The information directing the biosynthesis of any protein is encoded in the sequences of DNA nucleotides known as a gene. The DNA of the cell may be viewed as the storage 5 form of the genetic information. The DNA molecules are large, chemically stable, easily replicated and contain many gene sequences. For example, the entire genetic repertoire of the bacteria E. coli is contained in a single DNA molecule composed of approximately 4.2x106 nucleotide base pairs.
Transcription is the process by which the retrieval of information is begun. Transcription involves the resynthesls of the informatlon in the form of a nucleic acia called ~NA. O~e type of RN~, messenger ~NA ~mR~A~, transports the information to the site of protein synthesis called ribosome.
Once the mRNA is synthesized from the gene the process of protein synthesis ma~ begin. This process is essentially one of molecular decoding, in which the nucleotide sequence of the mRNA provides a template for the synthesis of a particular protein. Since there is a change from a nucleic acid language into that of a protein language, this process of protein synthesis appropriately is referred to as translation. Continuing the analogy a bit further, it would be appropriate to think of the constituents of the nucleic acids, the nucleotides, as representing the alphabet of the nucleic acid language and the amino acids, the building blocks of proteins, as representing the alphabet of the protein language. During the process of translation not only are the languages changing but the alphabets are 3o changing as well. This is a particularly complex process which is known to involve over 100 types of molecules. As the mRNA is passed through the ribosome (much like the tape ~21S3~4 1 through a tape recorder) groups of 3 nucleotides (codons) are positioned such as to orient accessory RNA molecules, known as transfer RNA (tRNA), carrying a single amino acid into the proper alignment for the addition of the amino acid to the 5 growing protein chain.
Of special interest with respect to the subject invention is the coding ratio of nucleotides to amino acids.
As mentioned above this ratio is three nueleotides coding for one amino acid. Since it is neeessary to eode for twenty 10 different amino acids uniquely with the available four types of nucleotides ~A, U, G, C~, three represents the minimum accepta~le rati~. A coding ratio of one nuc~eotide to one amino acid would only accomm~date f~ur of the twenty amino aeids necessary for protein synthesis. A coding ratio of two 15 yielding 16 (42) eombinations likewise falls short of the required eomplexity. However, with a eoding ratio of three, 64 (4 ) different eombinations are possible. This excess of twenty eode words eonfers upon the genetic code a eondition known as degeneraey. A degenerate eode contains several different code words for the same amino aeid. The situation does not exist, however, where one eode word would speeify two different amino acids. The code may be degenerate, but it is not ambiguous.
Knowing the sequence of nucleotides of a messenger RNA, it is possible to explicitly write the sequence of amino aeids eoded therein, but the reverse is not true. Because of the degeneracy of the genetie eode, a number of nucleotide sequences would be eonsistent with a given amino acid sequence. For example, consider the fragments of a mRNA from 3o the same gene in two different individuals "A" and "B".
INDIVIDUAL "A" INDIVIDUAL "B"
mRNA [UUC CCC CGA GUU CUA AAG] [UUU CCG AGG GUC CUU AAG]
protein [phe-pro-arg-val-leu,lys] lphe-pro-arg-val-leu-lys]

lZlS3Q4 1 An analysis of the protein would indicate the two individuals are identical, whereas an analysis of the mRNA
sequence would indicate clear differences. Any paternity test based on a protein analysis be it either immunological 5 or biochemical would fail to distinguish between the two individuals. A test based on the analysis of the genetic material, either ~A, or pre~erably ~N~, w~u~d allow such a distinction to be made.
Although the discussion above has centered on 10 determination of paternity in humans it should be kept in mind that such tests, given the appropriate reagents, may be extended to include certain other animal species (e.g., horses, cows, dogs, etc.). In reference to the subject invention, because of the unique approach taken therein, the 15 test procedure is applicable to a determination of parentage in any group of sexually reproducing organisms including plants as well as animals.
In a further application of the subject invention, the genetic identity of individuals may be established. This 20 application is particularly useful in the area of forensic science or for the identification of strains of microorganisms, plants or animals.

The object of this invention is to provide a new and improved test for the determination of paternity in sexually reproducing organisms and to establish individual cenetic identity. These objectives are achieved by analyzing the DNA of said organism in respect to one or more ~olymorphic genetic regions, differentiating the 30 ?olymorphisms in terms of relative size of the genetic regions and by so doing characterize an individual member of the species.

~S3~ , l In one embodiment, DNAs derived from the offspring, the mother and for example the putative father are separately digested with one, or more, restriction enzymes and the resulting fragments are separated on the basis of size by 5 causing them to migrate through a gel matrix under the influence of an electric current. The polymorphisms are detected by hybridizing the ab~e-treated D~As with labe~led (e.g., radioactive) "probe" DNAs.
The probe DNAs are variable D~A fragments that ha~e lO been joined to a vector DNA which is able to replicate in a host cell (e.g., plasmid pBR322, bacteriophage lambda or ~13 in Escherichia coli, or SV40 in monkey cells) and then purified from the host cells.
The reacted probe DNAs allow visualization of the 15 position, and thus the sizes, o~ the DNA fragments of the offspring, the mother, and the putative father, whose sequences are homologous to those of the probe DNAs. Because the probe DNAs have been chosen on the basis of their being one allele from a polymorphic locus, the sizes of the DNA
fragments homologous to those of the probes will vary among individuals.
All DNA fragments possessed by the offspring will be derived from either the offspringls mother or father, barring mutations or certain other rare events. A comparison Of the sizes of the DNA fragments detected by the probe DNAs thus allows one to determine whether or not the putative father could be the biological father. For example, if the offspring's DNA yields a ~600 hase-pair ~ragment homolog~us to one of the pro~e DNAs, and if the mother's DNA lacXs this 3o fragment, then the biological father's DNA must contain it.
If the putative father's DNA lacks this fragment he can be excluded as the biological father.

~S;~4 1 In a further embodiment, samples of DNAs derived from a suspect and from physical e~Tidence (blood, s~in, sperm, etc.) at a crime scene may be compared by the use of the probes described above to establish identity bet~een the 5 samples and the suspect. Thus the DNA polymorphism with respect to the hybridization assay provides the forensic scientist with a "molecular fingerprint" to be included along with the rest of the analysis of physical evidence.
In yet another embodiment, a sample of DNA deri~ed from an individual is compared with that DNA derived from other members of a strain of organism on the basis of relative size for the purpose of establishing the strain identity or said individual.
Description of the Drawinys Figure 1 represents the autoradiograph described in ~xample VII.
Figure 2 represents the autoraaiograph as described in Example VIII.
Figure 3 represents the autoradiograph as described in Example IX.

In one of its embodiments, the instant invention consists of the four interrelated steps of: DNA isolation and restriction; gel electrophoresis and DNA blotting;
hybridization and washing; and finally autoradiography.
DNA Isolation and Restriction -The isolation of DNA from cell samples is carried out ~y art recognized procedures. DNA preparation involves cell lysis, sodium dodecyl sulfate and sodium perchlorate, 3o chloroform/isoamylalcohol extractions, and ethanol precipitation.

_9_ 12~S3()4 l Following its preparation each DNA sample is subjected to analysis with one or more restriction endonucleases. Restriction endonucleases are enzymes which recognize short specific sequences of ahout 4-7 nucleotide 5 base pairs and cleave the DNA at or near these sites.
Although there are more than 200 restriction enzymes from which to choose, the selection of any particular enzyme to employ in the test would depend on the type of sample DNA , the number of fragments required and the availability and lO cost of the reagents.
The human genome, which consists of approximately 6x109 base pairs of DNA, would be cleaved into 106 to 107 discrete fragments ranging in size from 102 to 105 base pairs by a single restriction endonuclease. The 15 complexity of such a digest is a reflection of the number and location of the endonuclease specific cleavage points within the sample DNA. An exhaustive identification of each fragment from parallel treatments involving a number of different endonucleases would, in theory, result in a "molecular fingerprint" which would be unique for each human being, Although theoretically possible, such a detailed analysis is impractical. The subject invention overcomes this problem by permitting the analysis of a subset of the existing cleavage products. Employing the jargon of the genetic engineer's art, one is said to "probe" the existing cleavage products for the existence of the unique nucleotide sequence of interest. One well known method for accomplishing this analysis is the technique of ~outhern blotting.
3o ~.2153~4 l Gel ~lectrophoresis and Blotting According to the method of Southern (J. Mol. Biol.
~8:503-17 (197S)) the double stranded DNA ~ragments obtained from the treatment with the restriction endonuclease are 5 separated by size by electrophoresis in an agarose gel, and the DNA made single stranded by soaking the gel in alkali.
The gel is placed flat onto a "wick" of filter paper that connects with a trough containing concentrated salt solution.
A single sheet of cellulose nitrate is then placed lO on top of the gels and a large stack of dry absorbent paper towels laid flat on top of the cellulose nitrate. The salt solution is drawn up by the absorbent paper towels, passing through the gel and cellulose nitrate sheet. As the solution passes through the gel, the single stranded DNA will be 15 leached from the gel and pass onto the cellulose nitrate filter. Cellulose nitrate has the property of binding single-stranded DNA, so all the DNA will be leached from the gel and pass onto the cellulose nitrate filter, Cellulose nitrate has the property of binding single-stranded DNA, so all the DNA will adhere to this support. The end result of this procedure will be a perfect replica of the DNA from the original agarose gel, but the DNA is now single-stranded and immobilized on the cellulose nitrate filter sheet. The DNA
size pattern from the original agarose gel is, nevertheless, faithfully preserved. Fragment sizes may be calibrated by comparison to marker DNA of known sizes.
Hybridization and Washing A hybridization reaction is said to occur when two single-stranded DNAs from different sources reassociate to 3o --ll--12153~4 1 form a double-stranded DNA owing to complementary base pairing b~tween the two interacting strands. DNA/RNA hybrids may also be formed by means of the analogous associations.
With respect to the subject invention a DNA/DNA
5 hybridization is performed. One contributory source of material for the hybridization reaction is the single-stranded DNA present in the Southern ~lots of the restriction fragments. The other sources of hybridizing strands are the so-called "probe" DNAs. These DNAs represent variable DNA
10 fragments chosen on the basis that they represent sequences corresponding to one allele of a polymorphic gene locus. A
full description of the isolation and characterization of the "probes" is presented in a subsequent section of this disclosure.
A variety of hybridization conditions are recog-nized in the art including 50 percent formamide at 40-50~C or moderate salt at 65-68C. Dextran sulfate may be used to enhance the rate of reassociation. After hybridization, the filters are washed extensively for remove background (unhybridized) probes. The washing procedure is carried out at elevated temperature and reduced salt concentrations to remove non-specific DNA/DNA hybrids as well.
Preparation of Probe DNAs As mentioned previously, the probe DNAs represent 25 variable DNA fragments, chosen on the basis that they represent one-allele of a polymorphic genetic region. In this context the polymorphism is one of length. The variability in fragment length is a result of a difference in the number and/or location of endonuclease restriction sites 3o which were attacked during the generation of the fragments.
Thus, if all individuals possessed a DNA fragment of similar ~lS3~4 l si~e which hybridized to the probe DNA, the region would be considered monomorphic and of little utility with respect to the subject invention. Whereas when individuals possess DNA
fragments of dif~erent sizes which hybridize with the probe 5 DNA fragment; then that fragment can be said to represent an allele of a genetic region which displays size polymorphism.
The evaluation of probes is then of critical importance and may be considered to consist of the two interrelated steps of probe generation and probe identification.
lO Probe Generation The generation of probes may ~e accomplished accordin~ to art recognized procedures for the construction o~ a collection of cloned DNA fragments The steps normally include: digesting a DNA sample with a specific endonuclease, recovering ~ract~ons of D~A of appropriate size ~rom the digest, precipitating the fragments, introducing the fragments in to an appropriate cloning vector, transforming a competent host organism with the vector, and recovering colonies containing the cloned probe DNA. A variety of endonucleoases and vectors exist which may ~e used in the generation of probes. The methods f~r accomplishing the cloning is well known in the art (see for example, Molecular _loning: A Laboratory Manual, T. Maniatis, et al., Cold Spring Harbor Lab 1982). Two human DNA probes generated in such a manner are pAW 101 and pLM 0.8. Samples of E. coli harboring pAW 101 and pLM 0.8 were deposited with The American Type Culture Collection, 12301 Parklawn Drive, Rockvi]le, Maryland on February 8, 1984 where they were assigned the accession numbers ATCC 39605 and ATCC 39604, respectively and the requisite fees were paid. Access to the cultures will be available during the pendency of the patent l application to one determined by the Commissioner to be entitled thereto under 27 C.F.R. 1.14 and 35 U.S.C. 122.
All restrictions on availability of said culture to the public will be irrevocably removed upon the granting of the 5 instant application and said culture will remain permanently available during the term of said patent. Should the culture become nonviable or be inadver-tently destroyed, it will be replaced with viable culture(s) of the same taxonomic description.
Alternatively, cDNA probes may also be employed.
These probes are generated initially from RNA by a reverse copying procedure and is detailed in Example II herein or EP0 Publication No. 0 0~4 796.
Irrespective of the method used to generate the 15 probes, once obtained, each probe must be evaluated for usefulness in the testing procedure.
Identification of Useful Probes To evaluate the efficacy of a particular probe from the collection of probes generated above, DNA is isolated from four different individuals and separately digested with a restriction endonuclease. These DNAs are subjected to agarose gel electrophoresis, running a mixture of three of the individuals' DNAs in one lane and a sample from the fourth individual in an adjacent second lane. The electrophoresed DNAs are blotted as described previously.
Single-stranded DNA is isolated from an individual clone selected from the group of potential probes containing clones generated above. The probe DNA is labelled and used to hybridize with the electrophoresed DNA of the four individuals. If the tested probe yields more bands in the lane with the three lndividuals' DNAs than in the lane with 1:~15;~4 l the one individual's D~A, it becomes a candidate to detect polymorphisms. Probes identified by the foregoing procedure are further tested by hybridization against a sufficiently large population of test individuals to effectively determine 5 the extent of polymorphism. Probes corresponding to regions with at least four different alleles present in the population with frequencies greater than 10% ~ach are incorporated into the test.
According to a preferred embodiment of the 10 invention, a collection of polymorphic probes are employed rather than the reliance on a single polymorphic probe. This use of multipIe probes increases the sensitivity of the test dramatically. ~or example, if ten different probes are employed and each probe identifies a polymorphic region consisting of eight equally frequent occurring alleles, approximately a million individuals could be uniquely identified.
The parameters to be evaluated when selecting a particular probe for inclusion in the collection comprise the 20 degree of polymorphism, that is, the number of alleles and the frequencies that the alleles are present in the population to be tested. The mere existence of a large number of alleles, e.g., 60, at a particular probe locus in and of itself would not ensure a useful probe if, for example, 99.9% of the population to be tested possessed one allele and the remaining 0.1% was distributed among the other 59 alleles. Thus, the frequency of occurrence of the various alleles is an important consideration.
The number of individual probes in a probe set 3o could be quite large, 100 or more, practical limitations would restrict the number to from 1 to about 40, more preferably from 1 to about 20.

1~53~;?4 1 The number of alleles per polymorphoric genetic locus can be large, from 2 to about 60 or more, but more preferably from 2 to about 40. Optimally, the alleles will occur in roughly equally frequency.
5 Autoradiography The hybrid is visualized by means of autoradiography. Prior to the hybridization, the probe DNAs are labelled with a radioactive isotope, usually 32p. The specific activity of approximate 108 counts per min per ug 10 of DNA is required and normally involves labelling with at least two labelled nucleotides (TTP and dCTP 400 Ci/mmol).
The radioactive hybridized probe is localized using art recognized procedures involving exposure of film to the radioactive emissions. The radioactive hybrids essentially 15 take their own picture hence the term autoradiography.
Although autoradiography is an art recognized procedure for the localization o~ the h~brid molecules, the invention is not restricted to this particular mode of analy-sis. The hybrids of interest may be detected by means of any suitable analytically detectable reagent. For example, fluorescent detection, colorimetric reactions, immunological reactions, or enzymes or other protein-labelled reagents are also useful in the detection of the hybridized probes.

3o 12153(~4 1 ~XAMPLE I
This example illustrates the isolation of DNA from human peripheral blood. DNA so isolated is useful in the evaluation of probe DNA.
Ten to twenty cc. of peripheral blood is collected using EDTA as anticoagulent (~lood may be processed immediately or frozen at 70C).
The blood is transferred to a 50 ml tube and an equal volume of lysing buf~er ( 1 mM MgC12; 1 mM
lO NaH2PO4, pH 6-~: 0.8% Nonidet P-40; 0.4% deoxycholic acid, sodium salt) is added. The tube is inverted 25-50 times to mix well.
The mixture is transferred to a 50 ml plastic Sorvall tube and spun in an SW 34 rotor at 10,000 rpm (12,000 g) for 30 minutes. The supernatant is disçarded and the pellet is suspended in 10 ml of TNE (10 mM Tris, p~ 8.3;
150 mM NaCl; 5 mM EDTA). The pellet is disrupted by shaking the tube violently. 1.5 ml of 10% SDS ~f.c. 1.0~) is added and inverted several times. Three ml of 5 M NaClO4 (f.c.
1.0 M) is added and mixed. An equal volume of chloroform:
isoamyl alcohol (24:1) is then added and the tube is placed on a New ~runswick gyrotory shaker at 3500 rpm for 15 minutes. The phases are separated by a 10 minute spin at 3,000 rpm in Damon centrifuge.
The aqueous (top) phase is removed with an inverted lO ml pipette, without cotton (a siliconized Pasteur pipette may also be used) and transferred to a fresh 50 ml tube. The organic (bottom) phase, is discarded , an equal volume of Chl:IAA (24:1) is added and extracted and separated as 3O before. The extraction is repeated until the interphase after phase separation is clear. This usually requires 3-5 extractions.

lZ~53~)4 lThe aqueous phase from the final extraction is transferred to a plastic beaker. Two to two and one half volumes of -20C 95% EtOH is added by slow pouring down the - side producing two phases; aqueous-DNA phase on bottom and 5 EtOH on top. A clean, dry glass rod is wound in this solution until the tw~ phases mixed. The DNA precipitates at the aqueous-~t~H interface and is collected on the rod.
After the two phases have mixed, the rod is removed and air dried for 10 minutes.
lOThe rod is placed in 15 ml tube and covered with parafilm. Three holes are punched into the parafilm with an 18 gauge needle and the sample is dessicated 20 minutes.
The parafilm is removed and 0.5-1.0 ml of 0.01X SSE ~1.5 mM
NaCl; 0.15 mM EDTA, pH 7.0), is added. The sample is capped 15 and suspended overnight at 4C on an Ames rocker.
The amount of DNA in suspension is determined by recording the O.D. of a l/20 dilution of sample. 25~ul of the DNA suspension is added to 475 ,ul of distilled water, transferred to a cuvette and the O.D. recorded at 260, 270 and 280 using a cuvette filled with 0.01X SSE to zero each reading. The concentration of DNA in the suspension in mg/ml (~g/,ul) equals the reading of a l/20 dilution at O.D. 260 because the O.D. 260 of 1.000 = 50 ~g/ml. A dilution is made 3o 1 to keep the O.D. 260 between 0.100 and 1.000 where the correlation between DNA concentration and O.D. is linear.
O.D. readings above 1.500 are not accurate. The ~.D. 260/280 should be 1.8 or greater and measures the amount of protein 5 contamination. For example the following O.D. values were recorded from 0.5 ml of a 1/20 dilution of a DNA suspension form peripheral blood:
260 270 280 260 260 concentration lO 0.350 0.280 0.190 1.25 1.84 0.35 ~g/~l 0.350 x 50 ~g/ml x 20 = 350 ~g/ml = 0.35 ~g/~l 3o 1S3~

This example illus-trates a method for the generation of human DNA probes.
A. Messenger RNA Isolation 1. Between 10 _108 human cells are suspended in 2 mls ice-cold Rin~er's and centrifuged at 2000X g for 5 minutes at 4C.
2. Following aspiration of the supernatant, the cells are resuspended in ice-cold lysis buffer. The buffer 10 being comprised of 0.14 M NaCl 1.5 mM MgC12 10 mM Tris-Cl pH 8.6 0.5~ NP~40 ~,OOG units/ml RNasin (Biotec)
3. The suspension is vortexed for 10 sec. then underlayed with an equal volume lysis buffer containing sucrose (24% w/v) and 1~ NP-40 and stored on ice for 5 minutes.
4. The suspension is centrifuged at lO,OOOX g for 20 minutes at 4C in a swinging-bucket rotor.
5. The turbid; upper (cytoplasmic) layer is recovered and an equal volume of 2X PK buffer is added.
2XPK buffer: 0.2 M Tris-Cl pH 7.5 25 mM EDTA
0.3 M NaC1 2~ S.D.S.
Followed by the addition of proteinase K at a final concentration of 200)ug/ml and incubation at 37C for 30 3o minutes.

121S3~4 l 6. The layer is then extracted once with phenol/chloroform and the aqueous layer recovered, to which is added 2.5 volumes of ethanol and stored at -20C for at - least 2 hours.
7. The fraction is centrifuged for 10 minutes at 5000X g at 0C and the resulting pellet washed with 75%
ethanol containing 0.1 M sodium acetate.
8. The nucleic acids are redissolved in a small volume (-50,ul) of:
S0 mM Tris-Cl pH 7.5 1 mM EDTA
9. To the resuspenaea iraction is added MgCl2 to a final concentration o~ lOmM and R~asin ~Biotec) to 200~
units Iml . The suspension is then incubated for 30 minutes at 37C.
lO. Following incubation, EDTA and SDS are added to a final concentration of lOmM and 0.2%; respectively.
11. The suspension is extracted with phenol/chloroform and Na acetate pH 5.2 is added to 0.3 M and the nucleic acids are precipitated with 2 volumes of ethanol.
12. The RNA in 70% ethanol is stored at -70C.
B. Selection of poly A RNA
1. Oligo ~dT)-cellulose is equilibrated in sterile 2x loading buffer. The buffer is composed of 40 mM
Tris-Cl pH 7.6.
1.0 M NaCl 2 mM EDTA
0.2% SDS

3o S3~4 1 2. The oligo- (dT) -cellulose is used to form a 1 ml column and washed with 3 column volumes each of:
a) sterile water b) 0.1 M NaOH/5mrl EDTA
c) sterile water 3. The effluent pH should be less than p~ 8Ø
4. The column i6 then washed with 5 volumes of loadi~g ~uf~er.
5. R~A isolated in step A is dissolved in sterile 10 H2O and heated to 65C for 5 minutes. An equal volume of 2x loading buffer is then added and the sample i5 cooled to room temperature ~25C),
6, The sample is then app~ie~ to the column and the flow-through is collected. The flow-through is then 15 heated to 65C, cooled and reapplied to the column.
7. The column is then washed with 5-10 volumes of loading buffer, followed by 4 volumes of loading buffer containing 0.1 M NaCl.
8. Fractions are collected and read at 0D26o.
Initial fraction will contain poly(A) RNA in high concentration while later fractions will have little or no OD260 absorbing material.
9. The poly(A) RNA is eluted from the column with 2-3 volumes of sterile:
10 mM Tris-Cl pH 7.S
1 m~l EDTA
0.05~ S.D.S.
10. Na Acetate (3 M pH 5.2) is added to the eluant to a final concentration of 0.3 M and 2.2 volumes ethanol are 3o then added.
11. The RNA is centrifuged at 0C at 5000X g for 10 minutes.

3~

;3~)4 l 12. The pelelt is redissolved in water.
(10 cells yields 1-5 ug p31y (A) RNA) C. Synthesis of the First DNA Strand 1. The reaction conditions below assumes a 5 starting amount of 50 ~g of polyA mRNA. For amounts greater or less than 50 g the reaction mixture may be scaled proportionately.
2. Reaction mixture comprising:
Final 10Rea~nt Amount to AddConcentration lO mM dATP 25 ~l 500 ~M
10 mM dGTP 25 ~l 500 ~M
10 mM dTTP 25 ~l 500 ~M
15 2 mM dCTp 25 ~l lO0 uM
5 X Reverse Trans-criptase buffer 250 mM Tris 8.2; 50 mM Tris 250 mM KCl; 30 mM 50 mM KCl;
6 mM MgCl2 MgC12 100 pl 200 mM DTT 25 ~l 10 mM
Poly(A) mRNA (50 ~g) RNasin (Biotec) 25 placental RNase inhibitor 5 pl Avian myleoblastosis virus reverse transcriptase 20 ~l 300 ~/ml 3o Oligo(dT) 12-18 600 ug/ml 37.5 ul 45 ~g/ml 32p_dcTp l-lO uCi/500 ~l reaction distilled H2O To final volume: 500 ~l 1 3. The reaction is performed in a 1.5 m]
siliconized Eppendorf tube and initiated by the addition of the mRNA.
4. The reaction mixture is incubated at 42C for 5 60 minutes, then 10 ul of 500 mM EDTA is added to stop the reaction.
5. 1 ~l of the reaction mix is precipitated with T.C.A. and counted to determine the efficiency of 1st stranded synthesis. Generally, 17-25~ e~ficiency is lO obtained, rarely as high as 40%.
6. ~0 ~ Ci of 3 P-dCTP/500 ul will yield a specific activity of 2.2x106 cpm/~g of single stranded DNA. The specific activity allows maintaining of the product in subsequent step without wasting too much o~ the cDNA.
7. The sample is extracted twice with an equal volume of phenol saturated with 50 mM Tris pH 8Ø
~ . The phenol is extracted twice with ~Jolumes of ether. After which is added 3 M Na acetate to 0.3 M.
9. Three volumes of 95~ ethanol are added and the 20 mixture is placed on dry ice-ethanol for 5-10 minutes then warmed to room temperature.
10. The mixture is spun in a microfuge ~or lS
minutes after which time the supernatant is discarded and the pellet washed with 75~ ethanol.
ll. The DNA is redissolved in 0.5 ml of 300 mM Na acetate and steps 9 and 10 are repeated.
12. The DNA is resuspended in 200,ul of distilled water, layered on 5-20~ alkaline sucrose gradient (30 mM
NaOH, 2 mM EDTA) and spun for 40 minutes in an SW-40 rotor at 3o 37,000 rpm at 4C.

~Z~S304 l 13. 0.5 ml fractions are collected from the top of the gradient and place into 25 ~1 1 M Tris pH 6.8 and each fraction counted.
14. Five thousand-ten thousand counts per minute 5 from every other fraction are removed and run on an alkaline agarose gel. This permits a size distribution estimate to be made. Generally fractions which have cDNA of less than 500 nucleotides are discarded. Fractions particularly useful (i.e., at least 500 nulceotides long) usually occur at 10 fraction 12 from the bottom of the tube. Therefore while the gel is running and developing, fractions 1-10 lincluding the pellet) are pooled and dialyzed against 2 liters of water fractions 11, 12, 13 and 14 are also dialyzed but individually, The gel pattern will indicate whether or not further pooling is necessary. In general material greater than 500 nucleotides will account for 60% of the TCA-precipitable counts.
15. The ss cDNA is then concentrated with sec-butanol to a volume of ~400 ~ul followed by extraction of the butanol with ether.
16. To the extract is added 40 ul 3 M Na acetate and the remainder of the tube is filled with 95~ ethanol.
Precipitate on ethanol-dry ice for 5 minutes then place the tube in a water filled bucket of SW-27 rotor and centrifuge at 25,000 rpm for 60 minutes.
17. The ethanol is decanted and counted. The ethanol should contain less than 1% of the counts. Wash the pellet with ethanol and count the wash solution again; less then 1% of the counts should be removed. All counts should 3o remain in the pellet which is lyphilized for 10-20 minutes and then resuspended in 100 jul of water.

1;~1S~4 l D. Second Strand Synthesis With Klenow 1. The reaction mix below is for a 1 ml reaction at a concentration of ss cDNA of 2-5 ~g/ml.
Final Reagent Amount to Add Concentration 10 mM dATP, TTP, CTP, GTP 50 ,ul 500 pM
700 mM KCl 100 ~l 70 mM
5 mM mercaptoethanol100 ~l 0.5 mM
(~dd 1.8 ul of stock Eastman ~14 M) t~ 5 m~
H2~ to yield 5 mM) 10 x Xlenow buffer 100 ~ 30 mM Tns 300 mM Tris pH 7.5 4 mM MgCl2 40 mM MgCl2 Klenow polymerase Boehringer-Mannheim 150-200 units/ml SS c DNA 2.5 ~g distilled H2O To final volume of 1000 ~1 2. The reaction is incubated at 18-20C for 5-6 hours.
3. The mixture is extracted twice with phenol-Tris 25 pH 8 and ether.
4. An aliquot (2-10,000 cpm) is saved for gel analysis.
5. The remaining extract is dialyzed over night against water in a colloidon bag.
3o E. S1 Reaction ~1S;~04 l 1. The volume of the Klenow reaction of step D
will increase to 5-6 ml during dialysis. The volume is adjusted to the next highest ml with d H20 and one-tenth volume of 10 x Sl buffer is added:
3 M NaCl 0.3 M Na Acetate pH 4.5 100 mM ZnCl2 2. S1 nuclease (Sigma) is added to a final concentration of 10 units/ml and incubated at 37C for 30 lO minutes and stop the reaction by the addition of 500 mM EDTA
to a final concentration of 100 mM. An aliquot is saved for gel analysis.
3. The reaction mix is extracted twice with phenol and twice with ether. The extract is then dialyzed for 5-6 15 hours at room temperature vs water with at least one change of water and then concentrated with sec-butanol to ~400 ,ul.
4. The sample is loaded onto a neutral 5-20%
sucrose gradient (0.1 M NaCl, 10 mM Tris, pH 7.5, 1 mM EDTA) and centrifu~ed at 37,000 rpm is ~W-40 rotor for 20 hours at 4C.
5. Fractions of 0.5 ml are collected from the top of the tube. Fractions 1-14 will contain ~500 bps of ds cDNA. Gels are run to verify the size distribution.
6. The fractions are dialyzed exhaustively overnight against distilled water.
7. The sample is concentrated to ~400 ~ul with sec-butanol and precipitated with Na acetate and ethanol twice. The pellet is washed each time with 75~ ethanol. The DNA must be contaminant free.
8. The ds cDNA is then lyophilized.
F Tailing Reaction .

1. The reaction conditions below are for 1 ~g ds 3~4 l cDNA and may be scaled up or down accordingly.
Stock solutions: 50~uM dCTP 10 m~l CoCl2 2X cacodylate buffer: 250 )ul 1.2 M Na-cacodylate, pH 7.19 with HCl 250 ~l 1 mM DDT
750~ul H2O

Reagent Amount to add lO 2X cacodylate buffer 200 ~l cDNA (50 ng/ul) 20 ~l (lug) 50 ~M dCTP 40 ~l 20 ~M CoC12* 20 ~l 25 mg/ml BRL nuclease free BSA 8 ,ul 15 dH2O 68 ~l TdT IBethesda Res. Lab) 44 ~1 (760 u/ml final conc) * Add CoC12 just before BSA ~r it will precipitate, 2. The reaction mixture (-TdT) is incu~ated at 20C for 20 minutes.
203. The TdT is then added and the incubation continued for another 20 minutes.
4. The reaction is stopped by the addition of 8)ul of 500 mM EDTA and then extracted twice each with phenol then ether.
255. The sample is precipitated as above with sodium acetate, ethanol in the S~-27 rotor.
6. The pellet is washed with 7.5~ ethanol, lyophilized and resuspended in 50~ul of distilled water.

3o -2~-lZ~S~Q4 1 G. A ealing Tailed cDNA to plasmid-dG
1. The annealing reaction is performed in 10 ~1 sealed capillary tubes.
2. The reaction mix comprised:
ds cDNA 1 ~ul (5 ng) plasmid 1 ~1 (20 ng) lOX annealing buffer 1 M NaC1 100 mM Tris; pH 7.5 10 mM EDTA
distilled H20 7 ~ul 3. The mixture is incubated at 68 for 8 min~tes, then at 42~C for 2 hours after which time the water bath is turned off and the reaction mix allowed to equilibrate to room temperature (5 hours - overnight).

3o lZlS3~4 This example illustrates the methods of identification of probes which are useful in the detection of polymorphisms in humans.
1. DNA is isolated from the peripheral blood of 4 different human subjects as described in Example I.
2. The four samples of DNA are restricted separately with restriction enzyme EcoRI according to the following procedure.
a) The following components are added to a 1.5 ml eppendorf tube:
(1) Enough of the DNA solution for lO~ug (usually between '10 ~l and 50 ,ul).
(2) Distilled water, if necessary, to adjust to ~he final reaction volume.
(3) The appropriate amount of the specific 5X
endonuclease digestion buffer made to the manufacturer's recommendations.
(4) Restriction endonuclease in 1.5 to 2.5 fold excess, i.e., 15 units to 25 units for a lO~ug digestion.
b) The mixture is vortexed 1-2 seconds or the tube is flicked with a finger several times to mix.
c) The mixture is spun in eppendorf micro-centrifuge 10-15 seconds to pellet reactants.
d) The pellet is incubated 2-16 hours at 37C.
e~ The reaction is stopped to store for future electrophoresis adding:
(1) 1/10 volume of 0.1 M EDTA, pH 7.0;
f.c. 10 mM
(2) 1/10 volume of 5% SLS; f.c. 0.5%.

~Q~

1 (3) 1/10 volume of 3 M NaCl or 3 M NaAcetate;
f.c. 0.3 M
(4) 2 to 2~ volumes of cold 95~ EtOH;
f,c. about 70%
The sample may be stored to -20C for up to several months.
Samples can be precipitated quickly by placing an eppendorf tube containing the digested DNA, stop reactants, and EtOH in a dry ice-EtOH bath for 2-5 minutes depending on 10 the volume until the EtOH is viscous. The samples should not be frozen. The sample is spun in microfuge to pellet.
f) To stop reaction which is to be loaded to gel immediately after digestion, add SX ficoll marker dye solution to a final concentration of lX. This is done with samples where the final volumes is less than 75 jul.
g) A typical reaction mixture is constructed as follows:
10mgDNA H 0 5x buffer EcoRI 0.lM 5% 3M 95 5~/,ul EDTA SDS NaCl EtOH
2020~ul 16~1 10~1 4~1 6.25iul 6.25,ul 7.0,ul 14.0~1 and incubated at 37C for 2 hours. The EDTA, SDS, NaCl, and EtOH are added as indicated and store at -20C or add 12.5 ~1 of 5X Ficoll marker dye and load on gel.
3. The DNAs are subjected to electrophoresis as described in Example II running 5 ,ug of each of three of the individuals DNAs in one lane and 5 ~lg of DNA from the fourth individual in an adjacent lane.
4. The electrophoresed DNAs are then blotted according to the following procedure:
3o ~lS3~4 l a) The D~A is denatured in the gel by transferring the gel to a blotting bowl (round pyrex, 190x100 mm) containing 250 ml of 1 ~I KOH, 0.5 M NaC1 and shaken at 200 rpm at room temperature on a New Brunswick gyrotory shaker 25 minutes for an 0.8~ gel to 30 minutes for a 1.2% gel.
b) Precut nitrocellulose sheets (9~2x15 cm) are placed in 200-300 ml of distilled water to thoroughly wet.
c) The solution is decanted and saved (KOH-NaCl solution may be used to denature up to 10 gels.) The gel is 10 rinsed with distilled water (200-300 ml). All rinsed water is removed with Pasteur pipette. 250-300 ml of 1 M Tris, pH
7.0 is added and shakein~ is continued at room temperature at 50 rpm for 35 minutes.
d) The gel is neutralized by decanting and add 250-300 ml of 1 M Tris, plI 7.0 and continuing to shake for 30 minutes. The Tris solutions are sa~ed and adjusted back to pH 7.0 with concentrated HC~ up to 10 times.
e) Optibnally, the gel is decanted, 250-300 ml of 1 M Tris, pH 7.0 is added and shaking is continued for 25 20 minuteS~
f) All of the Tris is decanted and removed with a Pasteur pipette. The gel is equilibrated by adding 250-300 ml of 6SSC (lX = 0.15 M NaCl, 0.015 M NaCitrate) and shaken for 20 minutes.
g) The distilled water is decanted from the nitrocellulose and 100-200 ml of 6X SSC is added.
h) Using a pyrex 28X18X4 cm tray add 600-700 ml of 6X SSC. A wick of two strips of Whatman 3 M (15~zx38 cm) is wetted in the 6X SSC solution. A plastic blotting platform ~18~xl9xl cm) is placed in the middle of the tray and the Whatman 3 M wick is centered on the platform so that each end is submerged in the 6X SSC solution.

~21S31~4 1 i) While wearing gloves, the gel is transferred from the bowl to the wick. The gel is rubbed with gloved fingers to ensure contact with gel and wick.
j) The presoa~ed nitrocellulose ISchleicher and 5 Schuell, Keene, N.H.) is placed on the gel and positioned over the lanes to be blotted. Rubbing with gloved fingers ensures contact of the gel and nitrocellulose and the appearance of no air bubbles. The gel not to be blotted is trimmed and discarded. Three pieces of a 1 ml pipette are 10 placed along each side of the gel to avoid short circuits.
One piece of Whatman 3 M (15~x9~) is wetted and placed on top of nitrocellulose. Another similar sized dry piece of Whatman 3 M is added. About 10 cm of lO~x12 cm brown towels (No. 237 Singlefold Garland Sof-~nit Towels; Fort Howard 15 Paper Company, Green Bay, Wis. 54305) are stacked on top of gel. Cover by plastic wrap pulling tight around tray. The apparatus is left for 12 20 hours at room temperature. The blotting platform is placed on top for weight.
k) The towels are removed (some of the top ones 20 may still be dry) along with two pieces of Whatman 3 M
exposing nitrocellulsoe paper. A new razor blade is used to cut the nitrocellulose sheet into three strips containing 2 or 3 lanes worth of DNA (2 lanes each with the 8-lane well former and 3 lanes each with the 10-lane well former). The lower left corner of each strip is nicked for orientation and one, two or three holes are punched into the bottom of the appropriate strips for identification. After the strips have dried, they can be labelled with a marking pen.

3o l l) The strips are placed in 250 ml of 2X SSC in a blotting tray. Each side of the strips are rubbed with gloved fingers to remove bits of aragose. The strips are placed on Whatman No. 1 filter paper to air dry for 10-20 5 minutes. The strips are then placed between two pieces of Whatman 3 M paper and wrapped in aluminum foil. The outside is labeled with marking pen and may be placed in vacuum in dessicator for up to 6 months.
5, E. coli MC1061 carrying recombinant plasmids lO are cultured in 100 ml L broth from an individual colony of the library generated in Example II and plasmid DNA is isolated according to the following procedure:
a) The cells are centrifuged at 5000 rpm for 5 minutes at 0C.
b) The cells are washed with ~ volume of TE (10 mM
Tris-HCl, 1 m EDTA pH8) at 0C, c) The cells are resuspended in 3 ml of 25%
sucrose, 0.05 M Tris HCl pH 7.5 at 0C and 0.3 ml lysozyme (10 mg/ml in 0.25 M Tris-HCl pH 7.5) is added; followed by incubation on ice for 5 minutes with occasional gentle swirling.
d) 1.2 ml of 250 mM EDTA pH8 is added and incubation on ice is continued for 5 minutes.
e) 48 ml of Triton solution:
2 ml 10~ Triton X 100 (Sigma) 50 ml 250 mM EDTA pH:
135 ml H2O
is added and incubated on ice for an additional 10 minutes.
f) The mixture is spun for 30 minutes at 25,000 rpm at 0C.

lZlS3l~4 l g) The supernatant is re~o~ed and the volume is adjusted to 8.7 ml followed by the addition of 8.3 g of CsCl and 0.9 ml of 10 mg/ml ethidium bromide (Sigma #E-8151). The refractive index should be between 1.390 and 1.396.
h) The sample is centrifuged at 35-38K at 20C for 48-72 hours and visualize the bands by illuminating the tube with long wavelength ultraviolet light.
i) The lower band which contains the supercoiled DNA is collected by side puncture of the tube with a 21 guage 10 needle.
6. The pAT 153-human DNA recombinants are labelled with 3 P by nick translation as is well known in the art ('IA Manual for Genetic Engineering. Advanced Bacterial Genetics" by Davis, R. W., Botstein, D. and Roth, J.R. 19~0 15 Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp.
168-170).
al 20 ,ul of water minus the volume of the DNA
solution which is to be added is placed in a microfuge tube.
b) 2.5 ,ul of 0.5 M Tris pH 7.5, 0.1 M MgS04, 10 mM pTT, 500 ~g/ml BSA is then added.
c) 2.5 ul of a solution containing 0.2 mM each dNTP followed by the addition of 100 mg of pAT 153 human recombinant DNA from step 5 above.
d) A DNase stock solution:
DNase 1 mg/ml in 50 mM Tris pH 7.5 10 mM MgS04 1 mM DTT
and 50% glycerol 3o i5 previously prepared and stored at -20C.

15;~(~4 l e) The DNase stock solution from (d) abo~e is diluted at 0C l/40,000 into ~0 mM Tris pH 7.5, 10 mM MgSO4 1 mM DTT and 50 ~g/ml BSA and 0.5 ul of the diluted DNase is added to the reaction mixture.
f) 10 ~Ci of each 3 P dNTP in aqueous solution is added.
g) The entire reaction is initiated by the addition of 0.1 ~l of 2 mg/gl E. coli DNA polymerase I and incubated at 14C for 3 hours.
h) 25 ~l of 0.02 M Na3 EDTA 2 mg/ml carrier DNA, and 0.2% SDS is added to stop the reaction.
i) The reaction mixture is loaded onto a 0.7x20 cm Sephadex G-50 (medium) column preequilibrated with 10 ~I Tris Na3 EDTA at pH 7.5 (TE) and washed with same.
i) 0.5 ml effluent samples are collected in polypropylene tubes. The DNA appearing after 2 ml of wash.
The location of the 32P-labelled DNA is followed with a hand-monitor and the first peak is collected ignoring the tail.
7. The labelled probe from step 6 is hybridized to the blotted genomic DNAs from step 4 according to the following procedure:
a) 300 ml of prehybridization solution is prepared as follows:
1) 100 ml 3X PO4 (0.75 M Na2PO4, 0.75 M
NaH2PO4, 0.01 M NaPyrophosphate ~
2) 90 ml 20X SSC (3 M NaCl, 0.3 M NaCitrate) 3) 92 ml distilled water 4) 15 ml 0.5% BFP (0.5 g per 100 ml each of;
3o bovine serum albumin, ficoll, and polyvinylpyrolidone-360) 12~4 1 5) 3 ml 5~ g/~ 1 ssDNA (denatured salmon sperm DNA), The solution is transferred to plastic bin with top (20x14~xlO~ cm) and heat to 68C in water bath. The filters to be hybridized are added and incubated for 4 to 6 hours at b) For hyhridization strips, 3 to 4 strips are wrapped around a siliconized glass vial and inserted into a plastic scintillation vial containing 2 ml of hybridization solution. For hybridization of nitrocellulose sheets in lO hags, the appropriate amount of hybridization solution is added and the bag sealed with heat from a Sears seal-it device, The hybridization solution is made as follows for hybridization in a vial:
(1) 80 ~1 o~% BFP
(2) 20 ~1 0.1 M EDTA, pH 7.0 (3) 20 ~1 10~ SDS
(4) 20 ~1 5 ~g/~l ssDNA
~5) varia~le 3 P nick translated pro~e to give 2-4x106 counts/ml (6) variable distilled water to adjust to l900jul boil 12 minutes; ice 7 minutes l7) lOOjul 20X SSC
2000,ul c) Wearing gloves, the strips are removed directly from the prehybridization solution and the appropriate 3 or 4 strips are wrapped around a siliconized glass vial (19x48 mm with cap) and inserted into a plastic scintillation vial (28 mm diameter) containing the prepared hybridization solution.
3o 3~

12153~4 1 Parafilm is wrapped aro~nd the canned lid. Tapping several times ensures the filters are all at the bottom of vial. The filters are incubated 20-24 hours at 68C in a New Brunswick gyratory water bath with slow shaking (setting 5 number 3). Note: If there are less than 3 strips to wrap around the vial, one or two blank strips which have been prehybridized can be added.
d) The filters are washed in 2X SSC, 0.5% SDS as follows: 6-9 liters of wash solution is prepared depending lO on the number of filters to be washed. To a glass carboy with stopcock at the bottom is added:
(1~ 600 to 900 ml 20X SSC
(2) 300 to 4~0 ml 10% SDS
(3) 5100 to 7650 ml distilled water 15 A stir bar is placed at the bottom and a thermometer is suspended from the top. The solution is heated to 68C on hot plate with stirring.
1 to 1~ liters of wash solution is collected in plastic bin. The filters are removed after hybridization (wearing gloves) and immersed immediately in wash solution.
Millipore forceps are used to unroll and transfer filters.
e) The filters are transferred to 1 to 1~ liters of fresh wash solution and incubate 7-12 minutes at 68C in water bath. The first wash solution is carefully discarded down the drain with plenty of water to flush.
f) The filters are again transferred to 1 to 1~
liters of fresh wash solution. Continue to transfer every 7-12 minutes and incubate at 68C until all of the wash solution is used (4-7 washes).
3o ~2:1~;304 l g) The final transfer is to 1 liter of wash solution containing 0.1X SSC, 0.5~ SDS (945 ml distilled water, 50 ml 10% SDS, 5 ml 20X SSC) heated to 68C.
Incubation is at 68C for 10 minutes.
h) The filters are removed and rinsed in 500 ml of 2X SSC at room temperature. Filters are placed on sheet of Whatman No. 1 to air dry 15-30 minutes.
i) The 6 strips from two gels are taped on yellow paper from an x-ray film pack, labeled, covered with plastic 10 wrap and placed in cassette with built in intensifying screens. In dark room, the cassette is loaded with 8x10 inch X-Omat AR x-ray ~ilm placing film ~etween nitrocellulose strips and screen. The cassette is closed and placed in a freezer at -70C, j) The x-ray film is de~eloped in 24 to 48 hours.
The film is removed from cassette and developed in dar~ room with yellow safe light on. The cassette may be reloaded if another exposure is required.
8. If the tested probe yields more bands in the lane with three individuals' DNAs than in the lane with only one individual's DNA it becomes a candidate to detect polymorphisms.
9. Probes identified in step 8 are further tested by hybridizing them against a larger series of human DNAs to determine the extent to which the cloned region is polymorphic. Probes corresponding to regions with at least four different alleles present in the population with frequencies greater than 10~ each are incorporated into the test for paternity or the test for individual identity.
3o 12153~)4 This illustrates the performance and evaluation of a paternity test employing the subject invention.
1. Blood samples are taken from the mother, child, 5 and putative father and DNA purified as described in Example I.
~ . These DWAs separately reacted with restriction enzyme EcoRl as described in Example III.
3. These DNAs are subjected to electrophoresis as 10 described in Example II running 5 ~g of each of the mother's and the putative father's DNAs in one lane and 5~ g of DNA
from each of the three individuals in an adjacent lane.
4. The electrophoresed DNAs are blotted as described in Example III.
5. The set of "paternity probe" DNAs is lahelled with 32p as described in Example III.
6. The labelled probe DNAs from step S are hybridized with the blotted genomic DNAs from step 4 as descri~ed in Example III.
: 20 All genes of the child will be derived from either the mother or father. Therefore, if the putative father is the biologic father all bands present in the lane with the child's DNA will also be present in the lane w~thout the child's DNA. Conversely, if the putative father is not the 25 biologic father, new bands will appear in the lane with the child's DNA.

3o l~S304 This example provides specific techniques for and evaluation of a paternity test.
A. DNA PURIFICATION FROM BLOOD
1. Samples of blood (S to 10 ml) should be collected in tubes containing EDTA or Citrate as anticoagulant and stored at 4 C until processed.
2. Resuspend cells by inversion and centrifuge at 2,000 rpm for 10 minutes at 4 C. Remove serum ttop) without 10 disturbing buffy coat.
3. Add e~ual volume of blood lysis buffer ~0.32 sucrose, lOmM Tris pH 7.6, 5mM MgCl, 1~ ~riton X-100) at 4 C and mix well by inversion. Transfer into a 50 ml polypropylene conical tube (e.g. Corning, Falcon), rinse 15 blood tube and adjust final volume to 4 times the original blood volume. Mix well and centrifuge at 2,000 rpm for 10 min. at 4 C.
4. Decant supernatant. If pellet is not clean (i.e. too much red cell contamination), then resuspend pellet in 3 ml of lysis buffer and centrifuge again.
5. Resuspend whitish-pink pellet in 2.5 to 5 ml of DNA lysis buffer (10 mM Tris pH 7.4, lOmM EDTA, lOmM NaCl, 100 ,ug/ml of Proteinase K). Mix well and vortex if necessary. Add SDS (stock solution: 20%) to 1% final concentration. Mix by gently inverting the tube. The sample will turn very viscous. Place in rocker platform at 37 C
overnight with gentle mixing or at 60 C for 3 hours with occasional mixing.

3o 121S30~

1 6. Add NaC104 to 1 M final concentration from a 6 M stock (i.e. dilute 1:5). Mix gently by hand or in rocker platform~ At this point, the sample can be stored in the cold indefinitely.
7. Add equal volume of phenol-chloroform mix (1 part 90~ phenol, 10~ 1 M Tris pH 8.0 : 1 part CHC13) and gently shake (e.g. wrist shaker) for 15 to 30 minutes at room temperature.
8. Transfer to 15 ml glass Corex tube and lO centrifuge at 4,000 rpm for 15 min. (beckman) or 10,000 rpm for 5 min. (Sorvall) to separate the phases.
~. Remove ~o~ aqueous phase with wide mouth pipete and return to original plastic tube. Repeat this extraction procedure 2 more times.
10. Place DNA sample into an appropriately marked dialysis bag and dialyze against 100 fold excess of TE buffer (10 mM Tris pH 7.4, lmM.
11. Read O.D. of an appropriate sample dilution (e.g. 1/20) against same type of blank solution at:
240nm (for EDTA); 250 nm (max. for DNA), 270 nm (max for phenol); 280 nm (max. for proteins); 340 nm ~turbidity). 260/270 : approx. 1.2; 260/280 : approx. 1.8.
B. RESTRICTION ENDONUCLEASE DIGESTION OF GENOMIC
DNA:
1. Add the following components to a 1.5 ml eppendorf tube:
a) Take appro,ximately 10,ug of DNA/test (usually between 10 ~ul and 50 ,ul).
b) The appropriate amount of the specific 10X
3o endonuclease digestion buffer made to the manufacturer's recommendations.
c) Restriction endonuclease in 3 fold excess.

-~2-~21S3()4 l 2. Vortex 1 - 2 seconds or flick tube with finger several times to mix.
3. Spin in eppendorf microcentrifuge l0 - 15 seconds to pellet reactants.
4. Incubate 2 hours at 37 C for Eco Rl or 65 C
for ~
5. a) Add 1/10 volume of 3M NH4 Acetate.
b) 2 to 2 l/2 ~olumes of cold 95~ EtOH.
c) Store at -20 C overnight. Spin in microfuge ~o pellet 115 minutes at 4 C).
6. a) Dissolve pellet in 15 of H2O.
b3 Add the appropriate l~ X o~ restriction enzyme buffer and a 3 fold excess of restriction endonuclease and repeat steps 2, 3, and 4.
7. To stop reaction which is to be loaded to gel immediately after digestion, add 5X ficoll marker dye solution to a final concentration of lX. This can be done with samples where the final volume is less than 20 ~l.
C. BLECTROPHORESIS
l. Prepare agarose gel by boiling agarose in lX
TAN (40mM Tris, pH 7.9; 4 mM NaAcetate, lmM EDTA). Final concentration of agarose should be between 0.4~ and l.2%
depending on the size of the fragment to be fractionated.
Samples to be hybridized to pAW-l0l are electrophoresed in 0.4% agarose, while for hybridization to pLM 0.8 use l.2%
agarose.
2. When agarose solution reaches about 75 C, add EtBr (2,7-diamino-l0-ethyl-9-phenyl-phenanthridinium bromide) 3o to a final concentration from 500 ng/ml to 12.5 ng/ml.

~21~

l 3. Immediately pour into a horizontal gel electrophoresis mold to produce a gel approximately 4mm thick. Place a well former at one end of mold. Allow to cool at room temperature until solid. Remove well former and 5 cover ge~ with lX TAN.
D. Layer the samples into the gel wells. Connect the gel box to the power supply. Turn on thP power supply and dial up the current to the appropriate value. For example, to separate fragments of over 10 kb, electrophorese lO at 20 V for 3 days. For 1.5 kb fragments, electrophorese at 40 ~ overnight (16-20 hours) and after electrop~oresis, disconnect the tank. Wearing gloves, remove gel with gel scoop. Place gel on u.v. light box and lay a clear ruler along side the lane with marker DNA. Take a picture of the 15 gel with an appropriate photographic film to keep as a record of the electrophoresis, D. PLASMID QUICK PREP
1. 15 ml of E. coli HB101 carrying either pAW101 or pLMO.8.
2. Centrifuge 10 min. at 8,000 rpm.
3. Pellet vortexed.
4 . Add 300 of 25% sucrose; 50mM Tris pH 8.0; 0.1 EDTA; 0.2 mg/ml RNase; 1 mg/ml Lysozyme.
5. Leave in ice for 15 min.
6. Add 250 0.5% Triton X-100; 50mM EDTA; 50mM
Tris pH 8Ø
7. Leave for 5 min. on ice.
8. Spin at 4 C for 30 min. 25K in SW-25, 27 or 41.
3o 9. Separate pellet from supernatant. (Pellet is a gelation of bacterial DNA).

~Z~ 4 l 10. To the supernatant, add 10 of Proteinase K (5 mg/ml).
11. Leave 5 min. at R.T.
12. Extract once with l:l = phenol: CHCl3, twice 5 With C~IC13,
13. Aqueous phase add NH 4 Acetate to 0.3M final concentrate.
14. Add 2.5 X vol. ethanol.
150 Leave in freezer (-20 C) overnight.
16. Centrifuge, dissolve the precipitate in 20mM
Tris pH 7.4, 10 mM EDTA.
17. Add CsCl for banding~
E. NICK TRANS~ATION
1. For each hybirdization reaction mix:
a) 50 nanograms of native probe DNA.
b) 0.7 ,ul of lOX nick translation buffer (lX =
25 mM Tris. HCl pH 7.9, 2.5 mM MgCl, 5 mM DTT, 100 ~g/ml of bovine serum albumin).
c) 2.5 ul of alfa P-32 deoxynucleotides triphosphate (25 yCi).
d) O. 5 ,ul of DNAse I at 20 picograms/,ul.
e) 0.5 ~l of DNA polymerase I (3 units).
Final volume is adjusted to 5 ~l.
2. Incubate at 16 C for 2 hours.
3. Stop reaction by adding ~DTA to a final concentration of 10 mM and SDS to 0.5% final concentration.
Final volume 100 ~l.
4. Separate labeled DNA from unreacted 3o triphosphates by centrifugation of reaction mixture through 0.6 ml of SEpharose 6B-CL in a pierced microcentrifuge tube at 1500 rpm for 2 min.

~53Q4 l 5. Take 1 ~1 of the flow through material (i.e.
containing the labeled DNA, and count in a beta scintillation spectrometer.
F. SOUTHERN TRANSFER PROTOCOL FOR ZETAMIND
1. Run DNA on agarose gel. Stain with ethidium bromide ~10 ~g/ml) for 15 to 30 min., remo~e excess stain by soaking buffer for 15 to 30 min. and photograph.
2. Soak gel in 0.5 M NaOH, 1.0 M NaCl for 30 min.
with gentle agitation.
3. Rinse gel with water and repeat step 2 with 0.5 M Tris. HCl pH 7.5, 0.3 M NaC1, 4. Wet Zetabind with water. Then soak for 30 min.
in Na phosphate buffer ~0.025 M pH 6.5).
5. Soak gel for 15 min. in the same phosphate
15 buffer of step 4 for 20 min.
6. Place two strips of WHatman 3 MM wet in phosphate buffer, the size of gel. Make sure that there are no air bubbles trapped in between. Place gel (filters down) over tray with a 3 MM paper wick submerged in phosphate 20 buffer. Place Zetabind on the gel, then two 3 MM paper strips and finally paper towel (3-4 inches high). Place a flat tray on top and some weight (e.g. a 100 ml bottle) to ensure uniform contact between gel and papers.
7. Transfer overnight using phosphate buffer (0.025 m pH 6.5).
8. Wash membrane with phosphate buffer for 15 min.
(rub gently the side of the membrane that was in contact with gel).
9. Bake in vacuum oven for 2 hours at 80 C.
3o 10. Place in Seal-a-meal bag and wash for 30 to 60 min. at 60~ C in 0.1 X SCC, 0.5% SLS (approx. 15 ml).

~21S3Q4 l 11. Pour off buffer from step 10 and replace with prehybridization buffer (4 X SSC, S0 mM Na phosphate pH 6.7, 5 X Denhardt, 200 ug/ml of denatured salmon sperm DNA and 50%
formamide). Incubate 3 to 16 hours at 37 C.
12. Denature the probe by heating in 1 ml of hybridization buffer for 10 min. at 70 C. Hybridize with the denatured radioactive DNA for 40 to 72 hours at 37 C~2xlO dpm/bag).
13. Wash with 2 X SSCP, 0.1~ SLS at 65 C agitating lO for 20 min. until a 10 ml aliquot of the wash has less than 100 cpm Cherenkov (approx. 6 times). Wash twice with 0.4 X
SSCP, 0.02~ SLS at 65 C and twice with 0.1 X SSCP. Each time add enough buffer to co~er filters.
14. Blot Zetabina and let air dry ~efore covering 15 with cellophane and placing in the cassette for autoradiography.
Before reusing, remove probe by heating at 70 C
for 10 min. in prehybridization buffer.

20 PREHYBRIDIZATION (for 15 ml total volume) -1.5 ml denatured salmon sperm DNA (5 mg/ml) 3.0 ml 20 X SCC
1.5 ml 50 X Denhardt 1.5 ml 0.5 M phosphate 7.5 ml 100% formamide 0.15 ml 20% SLS
.
3o 32p _ labeled denatured DNA
1.5 ml more of 20 X SSC
\ ~

:~2:1~;304 1 HYBRIDIZAITON (for 15 ml total volume).
15. The 6 strips from two gels are taped on yellow paper from an x-ray film pack, labeled, covered with plastic ` wrap and placed in cassette with built in intensifying screens. In dark room, the cassette is loaded with 8 X 10 inch X-omat AR x-ray film placing fllm between nitrocellulose strips and screen. ~he cassette is closed and placed in a freezer at -70 C.
16. The x-ray is de~eloped in 24 to 48 hours. The film is removed from cassette and deeloped in dark room with yellow safe light on. The cassette may be reloaded if another exposure is required.

3o ~z~sa~

EXAMPLE VI
This Example illustrates the specific performance and evaluation of a paternity test employing the subject invention.
1. Blood samples are taken from the mother, child and putative father and DNA purified as described in Example V A.
2. These DNAs are separately reacted with either restriction enzyme EcoRl or Taq 1 as described in Example V

3. These DNAs are subjected to electrophoresis as described in Fxample V C using 5 ~g of one of the three DNAs in each of three adjacent lanes in order (from left to right) mother, child putative father.
4. "Paternity Probe" DNA' s are prepared and labelled as described in Examples V D and V E.
5. The electrophoreses DNAs are blotted as described in Example V F.
6. The labelled probe DNAs from step 4 are 20 hybridized with the blotted genomic DNAs from step 5 as described in Example V E. pAW 101 DNA is hybridized to EcoRl cut genomic DNA while pLM 0.8 is hy~ridized to ~ 1 cut genomic DNA .
7. Autoradiograms are made as described in Example 25 V F.
8. Following autoradiography, the size of the bands corresponding to the polymorphic DNA fragments are determined, This accomplished by measuring the distance migrated by these bands, relative to that of a collection of 3o D~A molecular weight standards (Southern, E.M., 11984] Anal.
Biochem. 100, 319-323).
The size of the DNA fragments, in each of the ~S3~4 1 individuals of a family, are compared and used to determine whether the pattern observed in the child is consistent with those measured in the putative father. If the size of the DNA fragments i the child are different to that of the 5 presumptive father, then it is concluded that he is not the biological father (i.e. case of non-paternity~. If the child shares only one allele with the mother then it can be concluded that the other allele was inherited form the father. If the putative father does not possess this allele 10 it can be concluded that he is not the father.
Alternatively, if the two share at least a pair of DNA
fragments, not co~tri~uted by the mother than the determination ~f whether or not that individual might be the father is based on the probability that a random indivi~al from the population might have that same DNA fragment size (i.e. paternity index; in Inclusion Probabilities in Parentage Testing [1983] , ed. R. H. Walker, American Association of Blood Banks). In this latter case it is necessary to know the frequency of the alleles detected with the particular DNA probe. The observed frequencies for the probes pAW-101 and pLM-0.8 are given in tables 1 and 2.

3o ~21~i~4 EXAMPLE VI I
Test Case 1 Using the procedures of Example VI a mother, child and putative father were tested using the subject invention.
5 Figure 1 shows a picture of the autoradiogram obtained using pAW101 as a probe against EcoR1 cut DNA obtained format he mother, child and father. Measurement of migration distances and comparison with known standards indicated that the mother carries pAW101-alleles number 2 and 5, the child carries 10 pAW101-alleles number 5 and 10 while the putative father carries pAW101-alleles numbers 10 and 11. Since the mother must have contributed pAW101-allele number 5 to the child the father must have contributed allele number 10. One now can compare the chance that the putative father would contribute 15 pAW101 allele number 10 to a child vs the chance that a random man would contribute allele number 10. In this case, the likelihood ratio if 16.67 which translates into a chance of paternity of 94%.

3o 1215;~04 Test Case 2 Using the procedures of Example VI, a mother, child and putative father were tested using the subject in~ention.
Fiqure 2 shows a picture of the autoradiogram obtained using pAW101 as a probe against EcoRl cut DNA obtained from the mother~ child and father. Measurement of migration distance and comparison with known standards indicated that the mother carries pAW101-alleles number 5 and 9, the child carries 10 pAW101-alleles numbers 5 and 7 while the putative father carries pAW101-alleles number 4 and 6. Since the father of this child must have contributed allele 7 to the child and the putative father does not carry this allele, he is excluded as a possible father.

3o S;~)4 Test Case 3 Using the procedures of Example VI, a mother, child and putative father were tested using the subject invention.
5 Figure 3 shows a picture of the aut~radiogram obtained using pLM ~.8 as a probe against Taq 1 cut DNA obtained from the mother, child and father. Measurement of migration distances and comparison with known standards indicated that the mother carries pLM 0.8-alleles number 7 and 8, the child carries pLM
10 ~.8-alleles number 7 and 8 while the putative father carries pLM 0.8-alleles numbers 2 and 8. Since the mother could have contributed either pLM 0.8 allele number 7 or 8 to the child one can only conclude that the father must have contributed either allele 7 or 8. One can compare the chance that 15 putative father would contribute either pLM 0.8 allele 7 or 8 to a child vs the chance that a random man would contribute either of these alleles. In this case the likelihood ratio is 3.55 which corresponds to a chance of paternity of 71.8%.

3o ~53Q4 Table I
Fre~uency of alleles visualized using pAW101 as a probe and Eco~l cut human genomic DNA in a population of 298 - random individuals.

Allele # Size Frequency (in kilobase pair) 1 14.0 0.013 2 14.5 0.052 3 14.9 0.077 4 15.4 0.117 16.0 0.1~6 6 16.6 0.117 7 17.2 0.064 8 17.7 0.040 9 18.3 0.035 lg.0 0.030 11 19.6 0.035 12 20.2 0.040 13 20.8 0.064 14 21.6 0.069 22.2 0.023 16 22.7 0.018
17 23.6 0.020
18 24.3 0.003
19 24.6 0.008 25.3 0.013 21 26.1 0.008 22 27.1 0.002 3o 23 28.1 0.002 ~;~15304 Table 2 Frequency of alleles visualized using pLM 0.8 as a probe and EcoRl cut human genomic DNA in a population of 268 - random individuals.

Allele # Size Frequency (in kllobase pair) 1 2.35 0.089 2 2.65 0.580 3 2.75 0.041 4 2.95 0.009 3.08 ~.123 6 3.40 0.0~7 7 3.70 0.123 8 4.09 0.018 9 4.30 0.007 3o

Claims (14)

WHAT IS CLAIMED IS:
1. A method for identifying an individual member of a species of organism comprising analyzing the DNA of said organism in respect to one or more polymorphic genetic regions, differentiating each polymorphism in terms of relative size of the genetic region and so characterizing an individual member of the species.
2. A method according to Claim 1 wherein said regions are detected by the steps comprising: a) isolating the DNA of the individual to be analyzed; b) subjecting said DNA to the action of restriction endonucleases; sizing and converting DNA fragments generated in step (b) above to single stranded molecules; c) hybridizing said sized, single-stranded molecules with probe DNA molecules; and d) identifying the number and location of said hybridized fragments, it being provided that said probe is not a cDNA of the human HLA genetic locus.
3. A method according to Claim 1 wherein said analyzed individual is a member of a species selected from the group comprising: viruses, bacteria, algae, fungi, plants and animals.
4. A method according to Claim 1 wherein the DNA
sample is obtained from cells of adult, juvenile, fetal or embryonic tissue.
5. A method according to Claim 2 wherein said probes comprise a set of probes wherein each individual probe within said set is selected as representing single allele of a different polymorphic genetic region.
6. A method according to Claim 5 wherein said probe set comprises from 1 to about 20 individual probes.
7. A method according to Claim 5 wherein the number of alleles contained with said polymorphic genetic region is from about 2 to about 40.
8. A method according to Claim 5 wherein said probes are pAW 101 (ATCC 39605) and pLM 0.8 (ATCC 39604).
9. A method according to Claim 1 which includes the further step of comparing the relative sizes of said polymorphic genetic regions of said individual with those of a presumptive mother and father for the determination of parentage.
10. A method of forensic analysis according to Claim 1 which includes the further step of comparing the relative sizes of said polymorphic regions from a first sample of an said individual with polymorphic regions derived from a second sample from another source for the purpose of establishing identity between the two samples.
11. A method according to Claim 1 which includes the further step of comparing the relative size of said polymorphic region of said individual with those derived from another member of a strain of organism for the purpose of establishing the strain identity of said individual.
12. A method for identifying an individual member of a species of organism comprising analyzing the DNA of said organism in respect to one or more polymorphic genetic regions, differentiating each polymorphism in terms of relative size of the genetic region and so characterizing an individual member of the species, wherein said regions are detected by the steps comprising: a) isolating the DNA of the individual to be analyzed; b) subjecting said DNA to the action of restriction endonucleases; sizing and converting DNA fragments generated in step (b) above to single stranded molecules; c) hybridizing said sized, single-stranded molecules with probe DNA molecules said probe molecules being further characterized as having been generated by endonuclease digestion of genomic DNA; and d) identifying the number and location of said hybridized fragments.
13. A method for identifying an individual member of a species of organism comprising analyzing the DNA of said organism in respect to two or more polymorphic genetic regions, differentiating each polymorphism in terms of relative size of the genetic region and so characterizing an individual member of the species.
14. A method for identifying an individual member of a species of organism comprising analyzing the DNA of said organism in respect to one or more polymorphic genetic regions, differentiating each polymorphism in terms of relative size of the genetic region and so characterizing an individual member of the species;
wherein said regions are detected by the steps comprising: a) isolating the DNA of the individual to be analyzed; b) subjecting said DNA to the action of restriction endonucleases; sizing and converting DNA
fragments generated in step (b) above to single stranded molecules; c) hybridizing said sized, single-stranded molecules with probe DNA molecules; and d) identifying the number and location of said hybridized fragments, it being provided that said probe does not hybridize to the human HLA
genetic locus.
CA000448439A 1983-02-28 1984-02-28 Test for the determination of paternity and the establishment of individual identity Expired CA1215304A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46811383A 1983-02-28 1983-02-28
US468,113 1983-02-28

Publications (1)

Publication Number Publication Date
CA1215304A true CA1215304A (en) 1986-12-16

Family

ID=23858481

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000448439A Expired CA1215304A (en) 1983-02-28 1984-02-28 Test for the determination of paternity and the establishment of individual identity

Country Status (10)

Country Link
JP (1) JPS59199000A (en)
AU (1) AU577277B2 (en)
BE (1) BE899027A (en)
BR (1) BR8400925A (en)
CA (1) CA1215304A (en)
DE (1) DE3407196A1 (en)
DK (1) DK118284A (en)
FR (1) FR2541774B1 (en)
GB (1) GB2135774A (en)
IL (1) IL71064A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880750A (en) * 1987-07-09 1989-11-14 Miragen, Inc. Individual-specific antibody identification methods

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8425059D0 (en) * 1984-10-04 1984-11-07 Biotechnica Ltd Identification technique
EP0342717A3 (en) * 1984-11-12 1990-04-25 THE LISTER INSTITUTE OF PREVENTIVE MEDICINE Royal National Orthopaedic Hospital Polynucleotide probes
IS1355B6 (en) * 1984-11-12 1989-04-19 Lister Institute Of Preventive Medicine Multicolor explores
GB8428491D0 (en) * 1984-11-12 1984-12-19 Jeffreys A J Polynucleotide probes
AU5698286A (en) * 1985-01-08 1987-04-24 Biotechnica Limited Determination of identity between two organisms
EP0221633A1 (en) * 1985-08-05 1987-05-13 Collaborative Research Inc. Genotyping by restriction fragment length polymorphisms
EP0226288A3 (en) * 1985-10-09 1989-06-28 Collaborative Research Inc. Means and method of testing for cystic fibrosis based on genetic linkage
GB8606719D0 (en) * 1986-03-19 1986-04-23 Lister Preventive Med Genetic probes
EP0402400B1 (en) * 1988-02-18 1999-09-08 University of Utah Genetic identification employing dna probes of variable number tandem repeat loci
WO1989010414A1 (en) * 1988-04-28 1989-11-02 Robert Bruce Wallace AMPLIFIED SEQUENCE POLYMORPHISMS (ASPs)
WO1991017262A1 (en) * 1990-04-30 1991-11-14 The University Of British Columbia Method of establishing identity
WO1993009249A1 (en) * 1991-11-01 1993-05-13 Immunogenetics Research Foundation Genetic analysis
ATE247716T1 (en) * 1994-02-07 2003-09-15 Beckman Coulter Inc LIGASE/POLYMERASE-MEDIATED ANALYSIS OF GENETIC ELEMENTS OF SINGLE NUCLEOTIDE POLYMORPHISMS AND THEIR USE IN GENETIC ANALYSIS
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
EP1950305A1 (en) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr a genes and uses thereof
BRPI0818971A2 (en) 2007-11-20 2017-05-16 Du Pont "plants, methods of altering root architecture in plants, methods of evaluating root architecture in plants, methods of determining alteration of an agronomic trait in a plant, isolated polynucleotide, vector, recombinant DNA construction, method of transforming cells, cell, plant production method, genetic variation mapping method and molecular cultivation method "
BR112012018601A2 (en) 2010-02-02 2015-09-01 Du Pont Plant, plant seed, method and polynucleotide isolated.
US10370673B2 (en) 2014-09-26 2019-08-06 Purecircle Sdn Bhd Single nucleotide polymorphism (SNP) markers for stevia
US20180265887A1 (en) 2017-03-16 2018-09-20 Jacobs Farm Del Cabo Basil Plants With High Tolerance to Downy Mildew

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717653A (en) * 1981-09-25 1988-01-05 Webster John A Jr Method for identifying and characterizing organisms
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
ATE53862T1 (en) * 1982-01-22 1990-06-15 Cetus Corp METHODS FOR THE CHARACTERIZATION OF HLA AND THE CDNS TEST AGENTS USED THEREIN.
DK105582A (en) * 1982-03-11 1983-09-12 Nordisk Insulinlab PROCEDURE FOR DETERMINING HUMAN HLA-D (R) TISSUE TYPES AND REVERSE FOR USING THE PROCEDURE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880750A (en) * 1987-07-09 1989-11-14 Miragen, Inc. Individual-specific antibody identification methods
US5270167A (en) * 1987-07-09 1993-12-14 Dicor Technologies, Inc. Methods of identification employing antibody profiles

Also Published As

Publication number Publication date
BR8400925A (en) 1984-10-02
DE3407196A1 (en) 1984-08-30
DK118284A (en) 1984-08-29
FR2541774B1 (en) 1987-04-17
AU577277B2 (en) 1988-09-22
AU2513884A (en) 1985-09-05
BE899027A (en) 1984-08-28
DK118284D0 (en) 1984-02-28
FR2541774A1 (en) 1984-08-31
JPS59199000A (en) 1984-11-10
GB8405107D0 (en) 1984-04-04
IL71064A (en) 1989-10-31
IL71064A0 (en) 1984-05-31
GB2135774A (en) 1984-09-05

Similar Documents

Publication Publication Date Title
CA1215304A (en) Test for the determination of paternity and the establishment of individual identity
Kanter et al. Analysis of restriction fragment length polymorphisms in deoxyribonucleic acid (DNA) recovered from dried bloodstains
US4581333A (en) Method of detecting and characterizing a nucleic acid or reactant for the application of this method
Wickham et al. Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies
JP2001507929A (en) Diagnostic method and diagnostic kit for genetic diseases by molecular combing
JP2000502260A (en) Methods for evaluating polymorphic gene sequences and their use in identifying HLA types
JPH03244400A (en) Cancer evaluation
JP2004523201A (en) Single copy genome hybridization probe and method for producing the same
EP0648222B1 (en) Methods of single nucleotide primer extension to detect specific alleles and kits therefor
JPH06504443A (en) DNA sequence related to isolated fragile X syndrome
Smith et al. Highly polymorphic minisatellite DNA probes. Further evaluation for individual identification and paternity testing
US5679514A (en) Method for determining the sex of birds
US6063567A (en) Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
Zimmerman et al. Exploiting structural differences among heteroduplex molecules to simplify genotyping the DQA1 and DQB1 alleles in human lymphocyte typing
US5691138A (en) Nucleotide sequences which hybridize specifically with a Campylobacter jejuni genomic nucleic sequence
US5593832A (en) Method for forensic analysis
Aquadro et al. RFLP analysis using heterologous probes
Dorit et al. Direct DNA sequencing of PCR products
US6440673B1 (en) Methods for identifying nucleic acid mutations using mismatch modification
EP0672179B1 (en) Nucleic acid analysis
US5605800A (en) Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
Gupta et al. Efficiency and cost effectiveness: PAGE-SSCP versus MDE and Phast gels for the identification of unknown β thalassaemia mutations
Sasaki et al. Relationship between call rate per individual and genotyping accuracy of bovine single‐nucleotide polymorphism array using deoxyribonucleic acid of various qualities
Schwarz et al. Methods for screening in cystic fibrosis
JPH10508499A (en) Nucleotide sequences that specifically hybridize to Campylobacter genomic nucleic acid sequences

Legal Events

Date Code Title Description
MKEX Expiry